Clinical Trial Update: Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rhTSH as an adjunctive diagnostic tool in differentiated thyroid cancer patients post-thyroidectomy versus after thyroid hormone withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Differentiated Thyroid Cancer | Phase 3 | Status: COMPLETED